Ernexa Therapeutics Inc [NASDAQ: ERNA] closed the trading session at $2.63. The day’s price range saw the stock hit a low of $2.36, while the highest price level was $2.65.
The stocks have a year to date performance of -40.36 percent and weekly performance of 10.62 percent. The stock has been moved at -39.33 percent over the last six months. The stock has performed -23.77 percent around the most recent 30 days and changed -36.68 percent over the most recent 3-months.
If compared to the average trading volume of 31.43K shares, ERNA reached to a volume of 117661 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Ernexa Therapeutics Inc [ERNA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ERNA shares is $900.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ERNA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Ernexa Therapeutics Inc is set at 0.37, with the Price to Sales ratio for ERNA stock in the period of the last 12 months amounting to 35.84.
ERNA stock trade performance evaluation
Ernexa Therapeutics Inc [ERNA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.62. With this latest performance, ERNA shares dropped by -23.77% in over the last four-week period, additionally sinking by -39.33% over the last 6 months – not to mention a drop of -90.87% in the past year of trading.
Ernexa Therapeutics Inc [ERNA]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Ernexa Therapeutics Inc [ERNA] shares currently have an operating margin of -2652.90% and a Gross Margin at -124.49%. Ernexa Therapeutics Inc’s Net Margin is presently recorded at -8618.69%.
Return on Equity for this stock declined to -168.48%, with Return on Assets sitting at -168.48%.
Ernexa Therapeutics Inc [ERNA]: Institutional Ownership
The top three institutional holders of ERNA stocks are: CYPRESS POINT WEALTH MANAGEMENT, LLC with ownership of 94375.0 shares, which is approximately 1.7445%. NAVITER WEALTH, LLC, holding 78796.0 shares of the stock with an approximate value of $$0.14 million in ERNA stocks shares; and NAVITER WEALTH, LLC, currently with $$0.13 million in ERNA stock with ownership which is approximately 1.3457%.
